PFE Latest Headlines

Bernstein Remains a Hold on Pfizer (PFE)

at www.tipranks.com (Wed, 10-Jun 7:39 AM)

4 stocks to watch on Tuesday: JBLU, GSK, PFE, NOVT

at seekingalpha.com (Tue, 9-Jun 8:58 AM)

Pfizer, Zai Lab win China nod for cervical cancer therapy Tivdak

at seekingalpha.com (Tue, 9-Jun 7:30 AM)

Pfizer Obesity Franchise Shows Promise but Competition, Execution Risks Keep Rating at Hold and Price Target Unchanged at $26

at www.tipranks.com (Tue, 9-Jun 2:35 AM)

Pfizer-Backed EV-309 Trial Targets Bladder-Sparing Edge in Muscle-Invasive Cancer

at www.tipranks.com (Mon, 8-Jun 12:33 PM)

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), Pfizer (PFE) and Novo Nordisk (NVO)

at www.tipranks.com (Mon, 8-Jun 9:30 AM)

BMO Capital Sticks to Their Buy Rating for Pfizer (PFE)

at www.tipranks.com (Mon, 8-Jun 8:05 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Pfizer (PFE)

at www.tipranks.com (Mon, 8-Jun 7:21 AM)

Analysts Conflicted on These Healthcare Names: Cullinan Management (CGEM) and Pfizer (PFE)

at www.tipranks.com (Mon, 8-Jun 5:50 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE), Dexcom (DXCM) and Glaukos (GKOS)

at www.tipranks.com (Mon, 8-Jun 5:20 AM)

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE)

at www.tipranks.com (Mon, 8-Jun 4:50 AM)

Pfizer Doubles Down on Vaccines and Cancer Ambitions

at www.tipranks.com (Sat, 6-Jun 11:02 AM)

Pfizer’s 22% Growth in New Products Highlights Strong Q1 Momentum; Pipeline and 2026 Guidance Affirmed

Market Chameleon (Tue, 5-May 8:03 AM)

Pfizer’s Lyme Disease Vaccine Candidate Achieves 73% Efficacy in Key Phase 3 Trial – Regulatory Submissions Planned

Market Chameleon (Mon, 23-Mar 7:09 AM)